Hybrid cereals are described which are obtained by restoring the pollen fertility for the Pampa cytoplasmic male sterility (P-CMS) and which are characterized by a reduced linkage drag. Plants are provided, in particular rye, which, as the male pollen parent, are capable of restoring the pollen fertility for the P-CMS. Furthermore, the nucleic acid molecule which carries the necessary information for restoring the P-CMS, DNA and vectors which contain such a nucleic acid molecule, corresponding host cells as well as a protein which can be encoded by the nucleic acid molecule and antibodies directed against it are also described. Furthermore, methods for the production of corresponding hybrid plants and transgenic plants are provided.

This invention relates to the Agrobacterium bacterium to be used in plant transformation method comprising three types of plasmids. The Agrobacterium bacterium of this invention comprises plasmids of (1) to (3) shown below: (1) a plasmid comprising the following components: (i) the virB gene, the virC gene, the virD1 gene, the virD2 gene, the virD3 gene, the virG gene and the virJ gene of pTiBo542, and (ii) an origin of replication; (2) a disarmed Ti plasmid or a disarmed Ri plasmid of Agrobacterium bacterium; and (3) a plasmid having a T-DNA region consisting of a desired DNA;
wherein each of the plasmids of (1) to (3) has a replication mechanism that enables a mutual coexistence with each other.

The present invention is in the field of soybean variety CA1154038 breeding and development. The present invention particularly relates to the soybean variety CA1154038 and its seed, cells, germplasm, plant parts, and progeny, and methods of using CA1154038 in a breeding program.

The present invention is in the field of soybean variety UB12520200 breeding and development. The present invention particularly relates to the soybean variety UB12520200 and its seed, cells, germplasm, plant parts, and progeny, and methods of using UB12520200 in a breeding program.

The disclosure discloses isolated polynucleotides and polypeptides, and recombinant DNA constructs useful for conferring improved tolerance in plants to insect pests; compositions (such as plants or seeds) comprising these recombinant DNA constructs; and methods utilizing these recombinant DNA constructs. The recombinant DNA constructs comprise a polynucleotide operably linked to a promoter that is functional in a plant, wherein said polynucleotides encode insect tolerance polypeptides.

Methods and systems are provided for generating and utilizing a bacterial composition that comprises at least one genetically engineered bacterial strain that fixes atmospheric nitrogen in an agricultural system that has been fertilized with more than 20 lbs of Nitrogen per acre.

A peptide comprised of either a binary or a tertiary peptide, the peptide contains at least 4 amino acids and up to a maximum of 16 amino acids, comprised of 2 or 3 different regions, wherein the binary peptides have 2 different regions and the tertiary peptides have 3 different regions; wherein, the peptide can be cleaved by both an animal gut protease and an insect or nematode gut protease.

Described herein are recruitment methods and compounds, compositions, and systems for recruitment. Such methods and compounds, compositions, and systems include the use of fusion proteins of Agrobacterium effector proteins, recruiting motifs, and/or nucleic acid binding polypeptides. Also described herein are methods and compositions for template editing of genomic DNA using Agrobacterium-derived T-DNA molecules and/or proteins.

Agrobacterium strains with mutations in the VirD2 gene and protein and expression constructs and genome-editing systems for leveraging the same. Methods are also provided for Agrobacterium-mediated incorporation of exogenous expressible nucleic acids into a host plant material using the Agrobacterium strains, expression constructs, and/or genome-editing systems.

Compositions including a virus-like particle (VLP)-based vaccine displaying a portion of ZIKV envelope protein (E) domain III (DIII) and a portion of ZIKV envelope protein (E) and related methods are disclosed herein. Further, compositions including vaccines comprising a portion of ZIKA virus E protein, wherein the portion of ZIKA virus E protein is either a full-length version of ZIKA virus E protein or a functionally equivalent version of the full-length ZIKA virus E protein, are disclosed.